Amylin Pharma (AMLN) Added To Goldman Sachs Conviction Buy List; Gilead (GILD) Removed
More News related to AMLN
- Canaccord Adams Reiterates Sell on Amylin (AMLN)
- Notable Analyst Rating Changes 9/2: AMLN, LOW, GOOG Upgraded; GILD, DF, NSC Downgraded
- Lazard Upgrades Amylin (AMLN) to Buy
- Top 10 News Items 8/25-8/29: Oil/Nat Gas See Volatile Trading on Gustav Concerns; Fannie/Freddie Nearly Double; FDIC Banking Profile Shows Worst Quarter Since '91
- BeaconEquity.com Issues Technical Trade Alerts on BioPharmaceutical Stocks: CEGE, AMLN, DNA, GENZ, AMGN, GILD
More News related to GILD
- Gilead (GILD) Lower On Fears of Flat HIV Growth Cited in BofA Downgrade, Another Analyst Takes Opposing View
- Notable Analyst Rating Changes 9/2: AMLN, LOW, GOOG Upgraded; GILD, DF, NSC Downgraded
- David Moenning's Daily State of the Markets: 9/2
- Banc of America Downgrades Gilead Sciences (GILD) to Neutral
- BeaconEquity.com Issues Technical Trade Alerts on BioPharmaceutical Stocks: CEGE, AMLN, DNA, GENZ, AMGN, GILD
More News related to Analyst Comments
- Atticus Capital Defends Itself After Hedge Fund Liquidation Rumor
- Plunge In Spectranetics (SPNC) Related to Federal Raid
- Reports Lehman (LEH) May Spin-Off $32B To 'Bad Bank'
- Governor Palin Gives eBay (EBAY) A Shout Out In RNC Speech
- Retail Sales Reflect Depressed Consumer Confidence
Amylin Pharmaceuticals Inc. (Nasdaq: AMLN) has been added to Goldman Sachs Conviction Buy List.
Gilead Sciences Inc. (Nasdaq: GILD) has been removed from Goldman Sachs Conviction Buy List.
Related Categories
Analyst CommentsStocks Mentioned
-0.37Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
